The clinical usefulness of histologic grading in follicular lymphoma (FL) is controversial and is further compromised by the subjective nature and poor reproducibility of most systems in current use. Therefore, we decided t o objectively evaluate the importance of cellular proliferation in FL, along with the current grading systems. We studied 106 patients with FL who were uniformly staged and aggressively treated. A proliferative index (PI) was determined quantitatively using an automated image analyzer and a new Ki-67 antibody that stains archival paraffin tissues. The cases were also subclassified according to the Berard, Rappaport, LukeCollins, and Jaffe methods, and survival analysis was performed. Patients with a low PI (C40461 had a significantly longer overall survival (OS) than those with a high PI (~40%).
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but the PI did not predict failure-free survival (FFS). The OLLICULAR LYMPHOMA (FLJ is generally considered to be a low-grade malignancy characterized by an indolent clinical course and a prolonged survival. Although long complete remissions can be induced in some cases, only a small proportion of patients with FL are thought to be cured with conventional the rap^."^ A number of clinical features have been associated with an adverse prognosis in FL, but the value of pathologic subclassification of FL with regard to therapy or prognosis is controversial.1-8 The usefulness of pathologic subclassification of FL is further compromised by the lack of uniform criteria for grading FL and poor diagnostic reproducibility due to the subjective nature of most grading system^.^"^ The level of proliferative activity, as determined by flow cytometric or cell kinetic studies, has been shown to correlate with tumor grade and have important prognostic implications in non-Hodgkin's lymphoma (NHL).12"7 The antibody Ki-67, which defines a proliferation-associated nuclear antigen,l8.l9 has been used in tissue sections of NHL to determine proliferative activity2' and has recently been found to also have prognostic v a l~e .~"~~ Although a number of small series have shown that proliferation increases with the number of large cells in FL,25-28 only one study has shown the potential utility of proliferation as an independent predictor of survival in low-grade However, the latter studyz9 excluded cases of follicular large cell lymphoma, and the patients were not uniformly staged and aggressively treated.
Therefore, we decided to objectively evaluate the importance of proliferative activity in a large group of patients with FL who were uniformly staged and aggressively treated. We also evaluated the importance of histologic classification of FL using four accepted methods (Rappaport, Lukes-Collins, Berard, and Jaffe). Finally, we evaluated the various clinical factors of potential prognostic importance in FL, including the recently developed International Prognostic Index for patients with diffuse aggressive NHL,30 and performed a multivariate analysis to determine which factors were independent predictors of survival in F L ,
F

MATERIALS AND METHODS
Patients.
The patients included in this study are all adults who were diagnosed with FL and were uniformly staged and treated at Only patients whose initial diagnostic biopsy displayed at least 70% follicularity were included in the study. Patients were evaluated before treatment with a complete history and physical examination, conlplete blood count, chemistry profile, chest radiograph, computed tomography of the abdomen and pelvis, and a bone marrow biopsy. The Ann Arbor system was used to stage the patients. During the early accrual period of this study, patients with localized disease received involved-field irradiation as the primary treatment. Subsequently, all patients received as primary therapy one of four closely related six-drug combination chemotherapy regimens including cyclophosphamide, doxorubicin or mitoxantrone, and procarbazine, plus bleomycin, vincristine, and prednisone or dexamethasone (CAP/ BOP). The details of the four treatment plans have been previously reported.' Of 130 eligible patients enrolled on this protocol, clinical data and adequate tissue for Ki-67 stains were available for 106 patients; of these 106 patients, 11 (10%) received involved-field irradiation only as the primary treatment for localized disease. A complete response was defined as the absence of demonstrable disease after the completion of therapy and restaging.
Pathologic features. All 106 cases had been previously subclassified using the Berard method" as follicular small cleaved cell (FSC), mixed cell (FM), or large cell ( K C ) type for the NLSG diagnosis of record. For the study, the cases were also subclassified by two pathologists (A.R.M. and W.C.C.) using the Rappaport and Lukes-Collins methods" and using a modified version of the Berard method recently described by Jaffe et al" ( Table I ). The tissue section with the greatest number of large cells present within the neoplastic follicles was used for this purpose and for immunostaining as described below. In the early phase of the study. more patients with the FLC type were enrolled than those with low-grade disease (FSC or FM) hecause of the existence of a competing noncurative treatment protocol for the latter group. However, since June of 1986. all patients with FL who could tolerate aggressive therapy were treated with CAP/BOP. Because of the small number of cases of FSC type (S cases) identified using the Berard or Jaffe methods, the FSC and FM cases were combined into one group for statistical analysis.
Ir,l,,lrrnosroini,l~ with Ki-67cmtibrxl~. Five-micron thick paraffin sections of formalin-fixed tissue were deparaffinized and rehydrated. To enhance antigen retrieval, sections were subjected to microwave incubation in citrate buffer at pH 6.0 twice for S minutes at full power and were then allowed to incubate in hot buffer for 10 minutes.
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The slides were incubated with polyclonal rabbit antihuman Ki-67 antibody (A 047 diluted 150: Dako. Carpinteria, CA)," stained with the avidin-biotin peroxidase complex technique, and developed with H20Z and diaminobenzidine (Sigma Chemical. St Louis. MO). and the nuclei were counterstained with 0.2% ethyl green in sodium acetate buffer. pH 4.0.
Qrtnnrirrrriw irncrgr crm/y.si.s. Quantitation of Ki-67 antibody staining was performed with the Cell Analysis Systems (CAS) 200 image analyzer7' using the CAS Quantitative Proliferation Software (Becton Dickinson. Elmhurst, IL) to obtain the percent nuclear area positive (PNA) and the cellular proliferation index (PI). These methods have been previously detailed and ~alidated.'~.". "."' Fifteen neoplastic follicular fields were analyzed in each case and the fields were selected from follicles with the greatest number of stained cells. Positive staining was identified as granular nuclear stain ( Fig  I) . The PNA value is calculated as the immunostained nuclear area divided by the total nuclear area which is ethyl green stained and is expressed as a percentage. The P1 value is similar to the PNA except that the immunostained nuclear area is first divided by the individual immunostained nuclear size estimate and the total nuclear area is divided by the overall nuclear size estimate, thus giving the percentage of positive cells.
Srcrristiccr/ cmcr/y.si.s. Curves of overall survival (OS) and failurefree survival (FFS) were drawn for the various histologic subgroups. by PI and PNA. and according to various clinical features of disease using the method of Kaplan and Meier." The cutpoints for the PI and PNA were determined by dividing the cases roughly into quartiles around the median PI (39%) and median PNA (32%). respectively. and evaluation of the curves of OS and FFS. Other cutpoints considering the PI and PNA as continuous variables were also evaluated. OS was defined as the time from initial therapy to death from any cause or to last follow-up. FFS was defined as the time from the onset of initial therapy to the first occurrence of progression, relapse after response, death from any cause, or to the date of last follow-up if none of these events had occurred. Survival curves were compared using the log rank testAx and all P values reported are two-sided. Although the International Prognostic Index"' describes four risk groups. ie, low, low intermediate. high intermediate, and high, we combined and compared the two low groups with the two high groups because the number of patients in the high risk group was small. A multivariate analysis to determine independent predictors of survival was performed using the Cox proportional hazards model for survival analysis."' For personal use only. on July 10, 2017. by guest www.bloodjournal.org From 43 (40) 85 (80) 21 (20) 79 (75) 27 (25) 63 (59) 43 (41) 21 (20) 78 (76) 
RESULTS
Clinical features.
The clinical characteristics of the entire group are summarized in Table 2 . The median age of the patients was 61 years (range, 23 to 84 years) and the median follow-up period was 46 months (range, 2 to 136 months). The predicted 5-year OS was 67% and the 5-year FFS was 39% (Fig 2) . By univariate analysis, the only clinical features that were predictive for OS were age (P = .098) and the International Prognostic Index ( P = .074). The clinical features that were predictive for FFS included the stage of disease ( P = .01 l), symptom status ( P = .034), number of involved extranodal sites (P = .01 l), Kamofsky score (P = .022), and the International Prognostic Index (P = .014).
Pathologic features. The effect of the PI on OS is shown in Fig 3. Patients with a low PI (<40%) had a significantly longer OS than those with a high PI (240%; P = .022).
However, the PI did not predict for FFS, and the PNA was not predictive of either OS or FFS. The number of cases by histologic subgroup for each of the classifications is shown in Table 3 . When the FSC and FM categories were combined, the cases in this subgroup in our series were identical when using either the Rappaport or Jaffe methods. Each of the methods categorized the cases quite differently, with the Berard method having the most FLC cases and the Rappaport or Jaffe methods having the fewest FLC cases. The mean PI correlated well with the subgroups in each of the classifications ( Table 3) .
All of the classification methods were predictive of OS (Fig 4) , but only the Berard method appeared to predict FFS (Fig 5) . Interestingly, using the Berard method, patients with the FSC/FM type had a better OS, but poorer FFS, than those with the FLC type ( Figs 4A and 5A) . The apparent plateau in the FLC FFS curve (Fig 5A) suggests that a proportion of patients with this type may be cured. The predicted 8-year FFS of patients with FLC was 47% (95% confidence interval [CI], 33% to 61%) versus only 17% for those with FSC/FM (95% CI, 2% to 32%).
The superiority of the Berard method as compared with the other methods for predicting FFS is shown in Fig 6 . Cases classified as FM by the Jaffe method but as FLC by the Berard method, ie, those cases with 15 or more large cells but less than 50% large cells per follicle, had the same FFS as those classified as FLC by both methods (ie, cases with 250% large cells per follicle). In contrast, the FFS of cases classified as FM by both methods, ie, cases with 5 to 14 large cells per follicle, fails to plateau and is characterized by a pattern of continuous relapse.
Multivariate analysis. A Cox proportional hazards model for survival analysis was used to determine which prognostic factors were predictive of OS and FFS when controlling for other factors found to be significant in the univariate analysis. For OS, only the histologic classification was an independent predictor. The Berard method was the best predictor of OS with a relative risk of death of 3.1 for those with FLC as compared with those with FSC/FM, whereas the Rappaport, Jaffe, and the Luke-Collins methods gave relative risks of 2.4, 2.4, and 2.1, respectively. Only the International Prognostic Index was an independent predictor of FFS, with a relative risk of failure of 2.3 for the high risk group (Fig 7) .
DISCUSSION
The subjective nature and poor reproducibility of most histologic grading systems of FL,9"' as well as ongoing controversy regarding the clinical value of such systems,"' led us to study our cohort of patients with FL who were uniformly staged and aggressively treated. Because a number of studies have indicated that proliferative activity is an important prognostic indicator in NHL,"-17. 2"2429 we decided to evaluate this parameter in an objective and reproducible manner. Image analysis is an ideal method for assessing proliferation in FL because it is rapid, objective, and reproplastic follicles with the greatest number of large cells. In our study, we used the automated, quantitative CAS image analysis system25~z7~34-36 and a new Ki-67 antibody that works in paraffin tissue,33 thus allowing the study of archival tisdUCible,25.27.' 5.36.40 and the analysis can be limited to the neo- sues. Previous studies of NHL have used a Ki-67 antibody that only works in snap-frozen tissue, thus limiting the number of cases available for study. However, one obstacle to the use of archival tissues is the variation in Ki-67 antibody staining of tissues that are fixed and processed at different institutions, and a number of cases had to be excluded from our study because of inadequate staining. The results that we obtained for FL with the CAS system are similar to those reported by Schwartz et a1: ' who also used the same system and methods. However, our results are difficult to compare with other reported results obtained by manual methods because only a small number of cases of FL have been so studied and the Ki-67 immunohistochemical, cell counting, and histologic classification methods used were quite heterogeneous. In four such s t~d i e s ?~,~"~~ the manual results were similar to our results, whereas in three other studies:0,22.44 two of which also included diffuse counterparts of FL,20,22 the results were somewhat lower. However, our study is the first to evaluate Ki-67 proliferative activity in FL and relate this parameter to survival. Similar to the study of Macartney et al?9 which evaluated the S-phase fraction of low-grade FL by DNA flow cytometry, we found that patients with FL having a low PI had a significantly longer OS than those with a high PI (Fig 3) . However, in our study, the PI was not predictive of FFS and was not an independent predictor of OS in the multivariate analysis. As in other smaller st~dies:~-~* we found that proliferation correlated with the histologic subgroups of FL in each of the various classifications (Table 3) , thus confirming the association of cellular proliferation with large-cell cytology in NHL.4' In contrast, Weiss et a 1 6 failed to find such a correlation in FL when using a manual, semiquantitative method to estimate Ki-67 proliferation rates. Interestingly, two studies have failed to show a correlation between the mitotic rate and survival in whereas a recent study found that abundant mitoses predicted for better survival in FLC NHL.48 However, our study indicates that the Ki-67 antibody can be used to provide important information with regard to the OS of patients with FL. Because of the subjective nature and poor reproducibility of methods for grading FL that require estimation of the percentage of large cells:"' we adopted the cell counting method of Mann and Berard3' some years ago for use by the NLSG. Nathwani et all' found that it was difficult for hematopathologists to reproducibly separate favorable from unfavorable FLs using subjective morphologic criteria alone and suggested that the cell counting method is superior to the estimation of percentages of large cells for grading FL. Although reproducibility may also be a problem with the Berard method: we have found this method to be less subjec- For personal use only. on July 10, 2017. by guest www.bloodjournal.org From tive and more reproducible than the other methods in our daily practice. However, when the Berard method is used, the proportion of cases in the various FL subgroups is different from that found by estimating percentages of large cells (Table 3 ). In our study, which was biased toward the inclusion of FLC cases (see Materials and Methods), the majority of FLs were classified as FLC type (60%) using the Berard method, whereas lesser numbers of cases were classified as such using the Lukes-Collins or RappapodJaffe methods (40% and 20%, respectively) . In a large and unselected survey of cases in the population-based registry of the NLSG,"9 we found that 16% of our cases of FL were classified as FSC, 37% as F M , and 47% as FLC type using the Berard method. Our more recent data is as follows: FSC 25%, FM 36%, and FLC 39%. These findings are roughly the reverse of what has been reported using more traditional metho d~.~~~~~ In the only study similar to ours, Nathwani et al"
categorized FL according to the Berard method and found the following: FSC 36%, FM 42%, and FLC 22%. However, the cases in this latter study" were highly selected and the distribution of cases may not be comparable to ours. The possibility that an excess of FLC NHL occurs in Nebraska, possibly because of heavy pesticide use,51 is also a consideration and will be the subject of a future study. However,
For personal use only. on July 10, 2017. by guest www.bloodjournal.org From these differing findings may have particular relevance to the comparison and interpretation of clinical studies that use different criteria for the selection and grading of FL.
In our study, we found that all of the classification methods were useful for predicting OS in FL (Fig 4) . In fact, histologic classification was the only independent predictor of OS in the multivariate analysis, with the Berard method being the best predictor of OS (relative risk, 3.1). The Berard method also appeared to predict for FFS, whereas the other grading methods were not predictive of FFS (Fig 5) . The apparent plateau in the FLC FFS curve (Fig 5A) suggests that a proportion of patients with this type of FL may be curable, as has been previously suggested by others using the Rappaport method.52"s although longer follow-up of our series will be necessary to confirm this finding. However, using the Berard method, Bartlett et a148 have recently reported results similar to ours with regard to prolonged FFS in aggressively treated patients with FLC NHL and have suggested that such patients should be treated with curative intent.
The superiority of the Berard method over the other methods for predicting FFS is further evident in Fig 6. It is apparent from these curves that some cases classified as FM type using the Jaffe method and other methods, ie, those cases with 15 or more large cells but less than 50% large cells per follicle, have an FFS that is identical to those with 50% or more large cells per follicle. In other words, such cases should probably be placed for clinical purposes in the FLC category, as with the Berard method. This same finding was also recently reported by Bartlett et aI4* and indicates that some cases classified as FM type using the other methods may be curable. Further studies with longer follow-up will also be necessary to confirm this finding. However, the results of our study suggest to us that the Berard method yields more clinically relevant information than the other grading methods for FL and that it should be used along with other methods in future clinical studies.
In our study, we found that the International Prognostic exception.58 In our study, multivariate analysis showed that the International Prognostic Index was the only independent predictor of FFS (relative risk, 2.3; Fig 7) . The International Prognostic Index, or modifications thereof, along with the Berard method of grading, should be useful in the design of future therapeutic trials of patients with €X and in the selection of appropriate therapeutic approaches for individual patients. For personal use only. on July 10, 2017. by guest www.bloodjournal.org From
